Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Capital Leases (2019 - 2022)

Historic Capital Leases for Agios Pharmaceuticals (AGIO) over the last 4 years, with Q1 2022 value amounting to $276000.0.

  • Agios Pharmaceuticals' Capital Leases rose 1129.03% to $276000.0 in Q1 2022 from the same period last year, while for Mar 2022 it was $276000.0, marking a year-over-year increase of 1129.03%. This contributed to the annual value of $276000.0 for FY2021, which is 1661.63% down from last year.
  • Latest data reveals that Agios Pharmaceuticals reported Capital Leases of $276000.0 as of Q1 2022, which was up 1129.03% from $276000.0 recorded in Q4 2021.
  • Agios Pharmaceuticals' 5-year Capital Leases high stood at $673000.0 for Q4 2019, and its period low was $167000.0 during Q2 2021.
  • For the 4-year period, Agios Pharmaceuticals' Capital Leases averaged around $340428.6, with its median value being $276000.0 (2021).
  • In the last 5 years, Agios Pharmaceuticals' Capital Leases plummeted by 5081.72% in 2020 and then soared by 1129.03% in 2022.
  • Quarter analysis of 4 years shows Agios Pharmaceuticals' Capital Leases stood at $673000.0 in 2019, then plummeted by 50.82% to $331000.0 in 2020, then dropped by 16.62% to $276000.0 in 2021, then changed by 0.0% to $276000.0 in 2022.
  • Its last three reported values are $276000.0 in Q1 2022, $276000.0 for Q4 2021, and $167000.0 during Q2 2021.